Clinical trials sponsored by Queen Mary University of London

Phase breakdown

Conditions studied

Recruiting trials led by Queen Mary University of London

• Artificial Intelligence-Assisted Magnetic Resonance Imaging for Quality, Efficiency and Equity in the National Health Service (NHS) Care of Multiple Sclerosis
  NCT07111637 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 99 Years · Sex: All (male and female) · 1 location
• Cardio-Renal Registry
  NCT06521801 · Phase: Not specified · Ages: 16 Years and older · Sex: All (male and female) · 1 location
• Children's Health, Respiratory Inflammation and Short-term Air Pollution
  NCT07431021 · Phase: Not applicable (e.g. observational or device study) · Ages: 7 Years to 11 Years · Sex: All (male and female) · 1 location
• Diagnosing Variable Primary Aldosteronism.
  NCT05765786 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Investigating Datopotamab Deruxtecan Plus Durvalumab Versus Datopotamab Deruxtecan in Patients With PDL1-negative Metastatic Triple-negative Breast Cancer
  NCT06954480 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Female · 2 locations
• Investigating Pathological Mechanisms in Non-alcoholic Fatty Liver Disease
  NCT04141592 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Natalizumab for the Treatment of People With Inflammatory Demyelination Suggestive of Multiple Sclerosis, or Definite Multiple Sclerosis, at First Presentation (AttackMS)
  NCT05418010 · Phase: Phase 2 · Ages: 18 Years to 55 Years · Sex: All (male and female) · 2 locations
• New bioMarkers tO straTIfy cOlorectal caNcer Referrals
  NCT07035691 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Population Based Germline Testing for Early Detection and Prevention of Cancer
  NCT07498829 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: Female · 2 locations
• SIZOMUS Safety of Ixazomib Targeting Plasma Cells in Multiple Sclerosis
  NCT03783416 · Phase: Phase 1 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 1 location
• The Barts Charity Children's Environmental Health Clinic
  NCT06447974 · Phase: Not applicable (e.g. observational or device study) · Ages: 4 Years to 17 Years · Sex: All (male and female) · 2 locations
• The Use of the CUE1/CUE1+ in People With Parkinson's Disease and Related Disorders
  NCT06174948 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Trans and Non-binary Prostate-Specific Antigen Reference Interval Determination Study
  NCT06987045 · Phase: Not specified · Ages: 40 Years to 100 Years · Sex: All (male and female) · 1 location
• Εffectiveness of a Digital Social Intervention in Primary Care
  NCT06849245 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 99 Years · Sex: All (male and female) · 5 locations

Common questions

How many trials is Queen Mary University of London recruiting for?

Queen Mary University of London is the lead sponsor of 14 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.